RCCA oncologists outline pioneering approach to clinical trials for cancer patients
Share on facebook Share on twitter Share on linkedin Share on email Share on print Enabling people with cancer to participate in clinical trials without
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
If you or a loved one is currently battling cancer, you’ve probably heard of something called clinical trials. Just at Regional Cancer Care Associates alone, more than 300 trials are conducted throughout New Jersey, Connecticut and Maryland. Clinical trials play an important role in the cancer community because they can help discover new treatments and offer hope to patients and their families.
Here’s just some of the ways that clinical trials help contribute to cancer care.
The purpose of clinical trials is to investigate new therapies, medications and techniques for cancer treatment. As new discoveries emerge, patients get one step closer to beating their specific type of cancer, including lung, colon, breast and prostate cancer.
But first, researchers need to make sure that these new methods are safe and effective for human use before making them available to the public. Without the process of clinical trials in place, new medications and immunotherapies would never get approved.
In cases where patients are no longer benefiting from existing treatment options, clinical trials can provide access to cutting-edge treatments that may prove more effective. Trying a new medication or therapy might be just what that patient needs. While not all clinical trials will be successful, many of them are. For added safety, the team at RCCA coordinates carefully with local physicians to create individualized treatment protocols for each candidate.
Even if a clinical trial is unsuccessful, it still offers important value to the entire cancer community. The participants’ results help doctors and researchers figure out what works and what doesn’t, so that they can continue working toward a cure.
And when a clinical trial is successful, new treatments can be made available. Hospitals will then be able to use the approved medications, devices or treatments to help save the lives of those dealing with cancer now and in the future.
If you’re interested in learning more about cancer clinical trials, or if you think you want to participate in one, contact your local RCCA office today. Our team is committed to providing value-based care to every patient, whether they’re fighting breast cancer, colon cancer or any other type of cancer, in order to achieve positive outcomes.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Share on facebook Share on twitter Share on linkedin Share on email Share on print Enabling people with cancer to participate in clinical trials without
Hematologic cancer, or blood cancer, is one of the most common diagnoses treated at Regional Cancer Care Associates. Blood cancer refers to types like leukemia
Deciding whether to participate in a clinical trial can be difficult, even if your oncologist recommends it. Ultimately, it’s your decision, and that can feel
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.